Identification of Structurally Related Antibodies in Antibody Sequence Databases Using Rosetta-Derived Position-Specific Scoring.


Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
06 10 2020
Historique:
received: 08 12 2019
revised: 16 06 2020
accepted: 22 07 2020
pubmed: 14 8 2020
medline: 14 8 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

The amount of antibody (Ab) variable gene sequence information is expanding rapidly, but our ability to predict the function of Abs from sequence alone is limited. Here, we describe a sequence-to-function prediction method that couples structural data for a single Ab/antigen (Ag) complex with repertoire data. We used a position-specific structure-scoring matrix (P3SM) incorporating structure-prediction scores from Rosetta to identify Ab variable loops that have predicted structural similarity to the influenza virus-specific human Ab CH65. The P3SM approach identified new members of this Ab class. Recombinant Ab expression, crystallography, and virus inhibition assays showed that the HCDR3 loops of the newly identified Abs possessed similar structure and antiviral activity as the comparator CH65. This approach enables discovery of new human Abs with desired structure and function using cDNA repertoires that are obtained readily with current amplicon sequencing techniques.

Identifiants

pubmed: 32783953
pii: S0969-2126(20)30245-8
doi: 10.1016/j.str.2020.07.012
pmc: PMC7544681
mid: NIHMS1620492
pii:
doi:

Substances chimiques

Antibodies 0
Antibodies, Viral 0
Complementarity Determining Regions 0
Epitopes 0
Hemagglutinin Glycoproteins, Influenza Virus 0
Immunoglobulin Fab Fragments 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1124-1130.e5

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201400024C
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI089554
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI117905
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests J.E.C. has served as a consultant for GSK Vaccines, Lilly, Sanofi and Sanofi Pasteur, Pfizer, and Novavax, is on the Scientific Advisory Boards of CompuVax and Meissa Vaccines, and is Founder of IDBiologics, Inc. All other authors declare there are no conflicts.

Références

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):264-9
pubmed: 23175789
Cell. 2019 Dec 12;179(7):1636-1646.e15
pubmed: 31787378
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21
pubmed: 21825125
J Clin Invest. 2016 Apr 1;126(4):1482-94
pubmed: 26950424
Cell. 2015 May 21;161(5):1026-1034
pubmed: 25959776
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
PLoS Pathog. 2014 Aug 28;10(8):e1004337
pubmed: 25166308
Nat Struct Mol Biol. 2009 Mar;16(3):265-73
pubmed: 19234466
Nat Biotechnol. 2018 Feb;36(2):152-155
pubmed: 29309060
Mol Immunol. 2000 Oct;37(14):837-45
pubmed: 11257305
Science. 2012 Jun 22;336(6088):1534-41
pubmed: 22723413
Proteins. 2015 Apr;83(4):771-80
pubmed: 25524709
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Acta Crystallogr F Struct Biol Commun. 2015 Feb;71(Pt 2):145-8
pubmed: 25664786
Nature. 2008 Sep 25;455(7212):532-6
pubmed: 18716625
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4446-51
pubmed: 27044078
Nat Protoc. 2007;2(1):31-4
pubmed: 17401334
Bioinformatics. 2016 Aug 15;32(16):2451-6
pubmed: 27153634
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Cell Rep. 2015 Dec 29;13(12):2842-50
pubmed: 26711348
Cell Discov. 2019 Apr 16;5:21
pubmed: 30993000
Scand J Immunol. 1991 Oct;34(4):509-18
pubmed: 1718028

Auteurs

Jessica A Finn (JA)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Jinhui Dong (J)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA.

Alexander M Sevy (AM)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA.

Erica Parrish (E)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA.

Iuliia Gilchuk (I)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA.

Rachel Nargi (R)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA.

Morgan Scarlett-Jones (M)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA.

Walter Reichard (W)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA.

Robin Bombardi (R)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA.

Thomas G Voss (TG)

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Jens Meiler (J)

Department of Chemistry and Center for Structural Biology, Vanderbilt University, Stevenson Center, Station B 351822, Room 7330, Nashville, TN 37235, USA. Electronic address: jens.meiler@vanderbilt.edu.

James E Crowe (JE)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232, USA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: james.crowe@vumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH